AVEO Pharmaceuticals Shares Popped: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: AVEO Pharmaceuticals (Nasdaq: AVEO  ) shares jumped as much as 20% this morning before going on a roller-coaster ride throughout the day.

So what: The stock bounced when RBC Capital Markets initiated coverage with an outperform rating and a $24 price target. The stock is relatively low volume and shares have returned to nearly flat as volume picked up later in the day.

Now what: Two analysts have initiated coverage over the past month and they are hardly in consensus. RBC Capital Markets has an outperform rating while MP Advisors has an underperform rating. With my skeptical view of analysts, and despite the $24 price target, I will wait for the company to show me positive results before jumping into shares.

Interested in more info on AVEO Pharmaceuticals? Add it to your watchlist.

Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1384438, ~/Articles/ArticleHandler.aspx, 11/27/2014 10:01:46 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement